Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0 | 0 | 0 |
Stocks | 100 | 100 | 0 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10 | 15 |
Price to Book | 2 | 2 |
Price to Sales | 2 | 2 |
Price to Cash Flow | 11 | 12 |
Dividend Yield | 3 | 3 |
5 Years Earnings Growth | 8 | 9 |
Name | Net % | Category Average |
---|---|---|
Industrials | 40 | 40 |
Financial Services | 26 | 21 |
Healthcare | 7 | 10 |
Technology | 7 | 8 |
Consumer Cyclical | 5 | 6 |
Real Estate | 5 | 4 |
Basic Materials | 4 | 5 |
Consumer Defensive | 3 | 5 |
Communication Services | 3 | 4 |
Utilities | 0 | 1 |
Number of long holdings: 342
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Atlas Copco A | SE0017486889 | 9.10 | 205.6 | +1.13% | |
Investor B | SE0015811963 | 7.91 | 285.4 | -0.26% | |
Volvo B | SE0000115446 | 5.46 | 287.30 | +0.70% | |
EQT AB | SE0012853455 | 3.57 | 342.00 | +0.62% | |
ASSA ABLOY B | SE0007100581 | 2.96 | 313.1 | +0.58% | |
SEB A | SE0000148884 | 2.90 | 150.55 | +0.47% | |
Hexagon B | SE0015961909 | 2.88 | 120.15 | 0.00% | |
Sandvik AB | SE0000667891 | 2.66 | 239.90 | +0.80% | |
AstraZeneca | GB0009895292 | 2.55 | 12,424.0 | +0.52% | |
H&M B | SE0000106270 | 2.41 | 186.1 | -1.06% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Sverige Indexfond | 41.58B | 7.66 | 4.68 | 10.72 | ||
SEB Varldenfond | 41.34B | 5.31 | 9.09 | 7.77 | ||
SEB Sverige Indexfond utd | 41.58B | 7.28 | 5.58 | 10.88 | ||
SEB Sverige Indexfond Institutional | 41.58B | 7.69 | 11.26 | - | ||
SEB Sverige Smabol C R utd | 25.79B | 8.40 | 7.44 | 17.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review